Dr. Kyle Christopher Rossi

M.D. | Epilepsy | 11+ years Exp


  41 Mall Rd, Burlington
     Massachusetts, 01805-0002
  781-744-8000    Maps & Directions
Dr. Kyle Christopher Rossi is a Burlington, Massachusetts based neurologist with 11 years of experience in Epilepsy Treatment. He completed his graduation from University Of Massachusetts Medical School in 2014. He is also affiliated with hospitals like He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Kyle Christopher Rossi is 274613 for Clinical Neurophysiology in Massachusetts. His current practice location is 41 Mall Rd, Burlington. Patients can reach him at 781-744-8000. Dr. Kyle Christopher Rossi is M.D. in Epilepsy Treatment and his NPI number (Unique professional ID assigned by NPPES) is 1760809743.
Dr. Kyle Christopher Rossi is focused on the diagnosis and treatment of patients with epilepsy, including new-onset, medically refractory epilepsy, psychogenic nonepileptic seizures, and epilepsy in special populations (the elderly, women, patients with co-morbidities). Epilepsy is a multidisciplinary field that provides comprehensive care of the patient.
Complete Profile:
Dr. Kyle Christopher Rossi speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Kyle Christopher Rossi
Specialization: Epilepsy Treatment
Gender:Male
Credentials: M.D.
Experience: 11+ years
Medical School Attended:University Of Massachusetts Medical School
Graduation Year:2014
Accepts Medicare Assignment:Yes
Practice Address:41 Mall Rd, Burlington,
Massachusetts, 01805-0002
Phone:781-744-8000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8820419914
Enrollment ID: I20200527002298
NPI Number: 1760809743
NPI Enumeration Date: 27 Mar, 2014
NPI Last Update On: 19 Jun, 2025

Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kyle Christopher Rossi are as mentioned below.
License NumberSpecializationStateStatus
274613Clinical Neurophysiology MassachusettsPrimary
274613Epilepsy Treatment MassachusettsSecondary
23112Neurology New HampshireSecondary
274613Neurology MassachusettsSecondary
23112Clinical Neurophysiology New HampshireSecondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN) State Hospital Type
(220163)Worcester, MAAcute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Kyle Christopher Rossi is associated with along with the number of members in that group.
Organization Name (Group PAC ID) Members
Umass Memorial Medical Group Inc (4284539891)1733
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Kyle Christopher Rossi such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
3122861MedicaidNew Hampshire
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Kyle Christopher Rossi
Po Box 415348,
Boston, Massachusetts
Zip: 02241-5348
Phone Number: 800-225-8885
Fax Number: 508-334-1977
Patients can reach Dr. Kyle Christopher Rossi at 41 Mall Rd, Burlington, Massachusetts or can call to book an appointment on 781-744-8000.
Comments/ Reviews:

*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.